TerrAscend (TSNDF) EBIT Margin (2021 - 2026)
TerrAscend's (TSNDF) quarterly EBIT Margin came in at 17.58% in Q1 2026, down 146.0% year-on-year from 38.21% in Q1 2025, and up 51.7% on a QoQ basis from 11.59% in Q4 2025.
TerrAscend (TSNDF) EBIT Margin (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of EBIT Margin data on file, last reported at 17.58% in Q1 2026.
- On a quarterly basis, EBIT Margin fell 146.0% year-over-year to 17.58% in Q1 2026; TTM through Mar 2026 was 15.77%, a 11.0% decrease from a year earlier, with the FY2025 full-year figure at 16.13%, up 161.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 17.58%, up from 11.59% in the prior quarter.
- Over the last five years, EBIT Margin for TSNDF reached as high as 23.86% in Q4 2023 and fell as low as 498.34% in Q3 2022.
- Historically, EBIT Margin has averaged 19.06% across 5 years, with a median of 15.83% in 2024.
- Across the five-year window, EBIT Margin plunged 49474 bps in 2022 and jumped 51820 bps in 2023, its largest moves.
- Year by year, EBIT Margin stood at 20.2% in 2022, then rose by 18 bps to 23.86% in 2023, then decreased by 26 bps to 17.56% in 2024, then plunged by 34 bps to 11.59% in 2025, then surged by 52 bps to 17.58% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 17.58% in Q1 2026, 11.59% in Q4 2025, and 17.11% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 17.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.58% |
| Dec 31, 2025 | 11.59% |
| Sep 30, 2025 | 17.11% |
| Jun 30, 2025 | 16.88% |
| Mar 31, 2025 | 19.04% |
| Dec 31, 2024 | 17.56% |
| Sep 30, 2024 | 11.13% |
| Jun 30, 2024 | 15.83% |
| Mar 31, 2024 | 7.53% |
| Dec 31, 2023 | 23.86% |
| Sep 30, 2023 | 19.86% |
| Jun 30, 2023 | 4.85% |
| Mar 31, 2023 | 5.48% |
| Dec 31, 2022 | 20.20% |
| Sep 30, 2022 | -498.34% |
| Jun 30, 2022 | -17.99% |
| Mar 31, 2022 | -16.26% |
| Dec 31, 2021 | 33.34% |
| Sep 30, 2021 | -3.60% |
| Jun 30, 2021 | 19.75% |